• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
KDM1A-mediated ZFP64 demethylation activates CENPL to promote epithelial ovarian cancer progression.KDM1A介导的ZFP64去甲基化激活CENPL以促进上皮性卵巢癌进展。
Cytotechnology. 2025 Feb;77(1):10. doi: 10.1007/s10616-024-00671-w. Epub 2024 Dec 1.
2
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.聚(ADP-核糖)聚合酶(PARP)抑制剂治疗卵巢癌。
Cochrane Database Syst Rev. 2022 Feb 16;2(2):CD007929. doi: 10.1002/14651858.CD007929.pub4.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation.小窝蛋白-1通过表皮生长因子受体(EGFR)降解抑制肺腺癌的增殖和侵袭。
Sci Rep. 2025 Jul 1;15(1):21654. doi: 10.1038/s41598-025-05259-8.
5
LINC00968 accelerates the progression of epithelial ovarian cancer via mediating the cell cycle progression.LINC00968通过介导细胞周期进程促进上皮性卵巢癌的进展。
Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4642-4649. doi: 10.26355/eurrev_201906_18043.
6
Nuclear factor IA-mediated transcriptional regulation of crystallin αB inhibits hepatocellular carcinoma progression.核因子IA介导的晶状体蛋白αB转录调控抑制肝细胞癌进展。
Mol Clin Oncol. 2025 Jun 20;23(2):72. doi: 10.3892/mco.2025.2867. eCollection 2025 Aug.
7
Silencing of LINC01278 promotes sensitivity of non-small cell lung cancer cells to osimertinib by targeting miR-324-3p/ZFX axis.LINC01278的沉默通过靶向miR-324-3p/ZFX轴促进非小细胞肺癌细胞对奥希替尼的敏感性。
Cytotechnology. 2025 Feb;77(1):23. doi: 10.1007/s10616-024-00673-8. Epub 2024 Dec 19.
8
KDM1A, a potent and selective target, for the treatment of DNMT3A-deficient non-small cell lung cancer.KDM1A,一种有效的、选择性的靶标,用于治疗 DNMT3A 缺陷型非小细胞肺癌。
Br J Cancer. 2024 Sep;131(4):655-667. doi: 10.1038/s41416-024-02772-x. Epub 2024 Jun 29.
9
Angiogenesis inhibitors for the treatment of epithelial ovarian cancer.血管生成抑制剂在治疗上皮性卵巢癌中的应用。
Cochrane Database Syst Rev. 2023 Apr 18;4(4):CD007930. doi: 10.1002/14651858.CD007930.pub3.
10
CEBPB regulates ERK1/2 activity through SOS1 and contributes to ovarian cancer progression.CEBPB通过SOS1调节ERK1/2活性并促进卵巢癌进展。
Med Oncol. 2025 Jun 7;42(7):242. doi: 10.1007/s12032-025-02794-2.

引用本文的文献

1
The Targeted Inhibition of Histone Lysine Demethylases as a Novel Promising Anti-Cancer Therapeutic Strategy-An Update on Recent Evidence.靶向抑制组蛋白赖氨酸去甲基化酶作为一种新型且有前景的抗癌治疗策略——近期证据更新
Cancers (Basel). 2025 Aug 27;17(17):2798. doi: 10.3390/cancers17172798.

本文引用的文献

1
Elevated EBF2 in mouse but not pig drives the progressive brown fat lineage specification via chromatin activation.小鼠而非猪体内升高的EBF2通过染色质激活驱动棕色脂肪谱系的逐步分化。
J Adv Res. 2024 Dec 28. doi: 10.1016/j.jare.2024.12.046.
2
Role of , , and in determining the prognosis of patients with lung adenocarcinoma.[具体内容缺失]、[具体内容缺失]和[具体内容缺失]在确定肺腺癌患者预后中的作用。
Transl Lung Cancer Res. 2024 Oct 31;13(10):2729-2745. doi: 10.21037/tlcr-24-696. Epub 2024 Oct 28.
3
Tanshinone IIA destabilizes SLC7A11 by regulating PIAS4-mediated SUMOylation of SLC7A11 through KDM1A, and promotes ferroptosis in breast cancer.丹参酮IIA通过KDM1A调节PIAS4介导的SLC7A11的SUMO化,使SLC7A11不稳定,并促进乳腺癌中的铁死亡。
J Adv Res. 2025 Mar;69:313-327. doi: 10.1016/j.jare.2024.04.009. Epub 2024 Apr 12.
4
E2F8-CENPL pathway contributes to homologous recombination repair and chemoresistance in breast cancer.E2F8-CENPL 通路促进乳腺癌同源重组修复和化疗耐药。
Cell Signal. 2024 Jun;118:111151. doi: 10.1016/j.cellsig.2024.111151. Epub 2024 Mar 22.
5
FOXA2-initiated transcriptional activation of INHBA induced by methylmalonic acid promotes pancreatic neuroendocrine neoplasm progression.FOXA2 启动的甲基丙二酸诱导的 INHBA 转录激活促进胰腺神经内分泌肿瘤进展。
Cell Mol Life Sci. 2024 Jan 22;81(1):50. doi: 10.1007/s00018-023-05084-0.
6
AI-Powered Segmentation of Invasive Carcinoma Regions in Breast Cancer Immunohistochemical Whole-Slide Images.人工智能辅助分割乳腺癌免疫组化全切片图像中的浸润癌区域
Cancers (Basel). 2023 Dec 29;16(1):167. doi: 10.3390/cancers16010167.
7
Top advances of the year: Ovarian cancer.年度重大进展:卵巢癌。
Cancer. 2024 Mar 15;130(6):837-845. doi: 10.1002/cncr.35135. Epub 2023 Dec 15.
8
CENPL accelerates cell proliferation, cell cycle, apoptosis, and glycolysis via the MEK1/2-ERK1/2 pathway in hepatocellular carcinoma.CENPL 通过 MEK1/2-ERK1/2 通路加速肝癌细胞的增殖、细胞周期、凋亡和糖酵解。
Int J Biochem Cell Biol. 2024 Jan;166:106481. doi: 10.1016/j.biocel.2023.106481. Epub 2023 Oct 31.
9
ZFP64 Promotes Gallbladder Cancer Progression through Recruiting HDAC1 to Activate NOTCH1 Signaling Pathway.锌指蛋白64通过招募组蛋白去乙酰化酶1激活NOTCH1信号通路促进胆囊癌进展。
Cancers (Basel). 2023 Sep 11;15(18):4508. doi: 10.3390/cancers15184508.
10
Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer.KDM1A/LSD1的药理学抑制增强了雌激素受体β介导的卵巢癌肿瘤抑制作用。
Cancer Lett. 2023 Oct 28;575:216383. doi: 10.1016/j.canlet.2023.216383. Epub 2023 Sep 14.

KDM1A介导的ZFP64去甲基化激活CENPL以促进上皮性卵巢癌进展。

KDM1A-mediated ZFP64 demethylation activates CENPL to promote epithelial ovarian cancer progression.

作者信息

Wang Jie, Fang Xinjian, Xing Yajun, Ding Meiqing, Zhu Liangxue, Wang Mingyun

机构信息

Department of Oncology, Gaochun People's Hospital Affiliated to Jiangsu Health Vocational College, No. 53, Maoshan Road, Gaochun Economic Development Zone, Nanjing, 211306 Jiangsu People's Republic of China.

出版信息

Cytotechnology. 2025 Feb;77(1):10. doi: 10.1007/s10616-024-00671-w. Epub 2024 Dec 1.

DOI:10.1007/s10616-024-00671-w
PMID:39628712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11609140/
Abstract

UNLABELLED

Lysine-specific histone demethylase 1A (KDM1A) has emerged as an attractive therapeutic target for treating various cancers, owing to its observed overexpression. However, its function in epithelial ovarian cancer (EOC) remains uncertain. The current study sought to investigate the function of KDM1A on malignant phenotypes of EOC cells as well as the underlying mechanism. Colony formation assay, cell counting kit-8, wound healing, Transwell assays, and TUNEL assays were performed to investigate the effects of KDM1A, Zinc finger protein 64 (ZFP64), and centromere protein L (CENPL) in vitro, while subcutaneous tumor formation models were established in nude mice to evaluate their roles in vivo. KDM1A, ZFP64, and CENPL were overexpressed in EOC tissues and cells. Knockdown of KDM1A, ZFP64, or CENPL inhibited the biological behavior of EOC cells. In addition, chromatin immunoprecipitation showed that KDM1A stimulated ZFP64 expression by removing the H3K9me2 mark from its promoter. Restoration of ZFP64 promoted EOC cell malignant phenotype in the presence of KDM1A knockdown. ZFP64 activated CENPL transcription. Reactivation of CENPL promoted the growth of EOC cells in vivo inhibited by knockdown of ZFP64. Collectively, KDM1A promoted EOC cell proliferation, migration, and invasion, and reduced apoptosis by activating the ZFP64/CENPL axis, which triggered EOC progression.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s10616-024-00671-w.

摘要

未标记

赖氨酸特异性组蛋白去甲基化酶1A(KDM1A)因其过表达而成为治疗多种癌症的有吸引力的治疗靶点。然而,其在上皮性卵巢癌(EOC)中的功能仍不确定。本研究旨在探讨KDM1A对EOC细胞恶性表型的作用及其潜在机制。进行集落形成试验、细胞计数试剂盒-8、伤口愈合试验、Transwell试验和TUNEL试验以研究KDM1A、锌指蛋白64(ZFP64)和着丝粒蛋白L(CENPL)在体外的作用,同时在裸鼠中建立皮下肿瘤形成模型以评估它们在体内的作用。KDM1A、ZFP64和CENPL在EOC组织和细胞中过表达。敲低KDM1A、ZFP64或CENPL可抑制EOC细胞的生物学行为。此外,染色质免疫沉淀表明,KDM1A通过从ZFP64启动子上去除H3K9me2标记来刺激其表达。在KDM1A敲低的情况下,ZFP64的恢复促进了EOC细胞的恶性表型。ZFP64激活CENPL转录。CENPL的重新激活促进了体内受ZFP64敲低抑制的EOC细胞的生长。总的来说,KDM1A通过激活ZFP64/CENPL轴促进EOC细胞增殖、迁移和侵袭,并减少细胞凋亡,从而引发EOC进展。

补充信息

在线版本包含可在10.1007/s10616-024-00671-w获取的补充材料。